drugset / Trial / NCT06880926

Antarctic Krill Oil for Knee Osteoarthritis Pain

NCT06880926 ↗

Phase 2 Not yet recruiting 116 enrolled Qilu Hospital of Shandong University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate the effectiveness and safety of Antarctic Krill Oil (AKO) as a dietary supplement in managing pain associated with knee osteoarthritis (OA). The main questions it aims to answer are: ①Does AKO reduce daily pain intensity in participants with moderate knee OA? ②What adverse effects do participants experience when taking AKO? Researchers will conduct a randomized, double-blind study comparing AKO to a placebo (identical appearance without active components) to assess: * Changes in joint pain severity; ②Functional improvement in daily activities; ③Biochemical safety parameters,etc.

Timeline

Start
2025-04-01
Primary completion
2026-02-28
Completion
2026-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Krill oil Other / unclassified 2 g Oral

Indications